2m 2m 2m 2m 2m 2m 2m
VERA THERAPEUT-A (VERA)
NASDAQ
$32.55+$0.27 (+0.85%)
Price as of Aug 21, 2026 7:58 PM EDT- $2.3BMarket Cap
- 43.00%1-Year Change
- BiotechnologyIndustry
VERA THERAPEUT-A (VERA)
$32.55+$0.27 (+0.85%)
VERA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $32.27 | ||
Change | +$1.02 (+3.25%) | ||
Open | $31.42 | ||
High | $32.97 | ||
Low | $31.03 | ||
Previous Close | $31.26 | ||
Volume | 1,288,427 | ||
30-Day Average Volume | 2,049,017 | ||
1-Week Change | 2.04% | ||
1-Month Change | -13.17% | ||
1-Year Change | 43.00% | ||
3-Year Change | 79.21% | ||
5-Year Change | 70.77% | ||
Fundamentals | |||
Shares Outstanding | 72.1M | ||
Total Assets | $533.0M | ||
Market Cap | $2.3B | ||
Enterprise Value | $2.4B | ||
Period: QTR TTM FY | |||
Revenue | -$247,000.00 | ||
Net Income | -$109.5M | ||
Free Cash Flow | -$100.3M | ||
EBIT | -$109.5M | ||
EBITDA | -$109.3M | ||
Net Working Capital | $479.2M | ||
EPS | -$1.52 | ||
Enterprise Value/EBITDA | -22 | ||
Enterprise Value/Revenue | -9,523 | ||
P/B | 6 | ||
P/E | -21 | ||
PEG | -2 | ||
Price/Free Cash Flow | -23 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue